{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T06:47:39Z","timestamp":1791355659472,"version":"4.3.1"},"reference-count":103,"publisher":"Oxford University Press (OUP)","issue":"11","license":[{"start":{"date-parts":[[2005,11,1]],"date-time":"2005-11-01T00:00:00Z","timestamp":1130803200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,11,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>In this review, we describe the history, epidemiology and clinical manifestations of infections attributed to respiratory syncytial virus (RSV) in children. At present, no cure exists for RSV infection but commonly employed palliative treatments include oxygen and inhaled \u03b22-adrenoceptor agonists, such as salbutamol, to relieve the wheezing and increased bronchiolar smooth muscle constriction. Adrenaline (epinephrine) has been found to be superior to the selective \u03b22-adrenoceptor agonists. Oral or inhaled corticosteroids should counteract the inflammatory response to RSV infection but their effectiveness is controversial. Inhaled ribavirin is the only licensed antiviral product approved for the treatment of RSV lower respiratory-tract infection in hospitalized children, although its use is now restricted to high-risk infants. Other treatments considered are nasopharyngeal suctioning, surfactant therapy, recombinant human deoxyribonuclease I, heliox (helium:oxygen) and inhaled nitric oxide. Prevention of infection by RSV antibodies is another strategy and, currently, palivizumab is the only safe, effective and convenient preventative treatment for RSV disease in high-risk populations of infants and young children. Its cost-effectiveness, however, has been questioned. Both live attenuated and subunit vaccines against RSV infection have been developed but so far there is no safe and effective vaccine available. Finding effective treatments and prophylactic measures remains a major challenge for the future.<\/jats:p>","DOI":"10.1211\/jpp.57.11.0001","type":"journal-article","created":{"date-parts":[[2005,10,12]],"date-time":"2005-10-12T21:08:17Z","timestamp":1129151297000},"page":"1371-1381","source":"Crossref","is-referenced-by-count":14,"title":["Respiratory syncytial virus infections: characteristics and treatment"],"prefix":"10.1093","volume":"57","author":[{"given":"Sharon M","family":"Chidgey","sequence":"first","affiliation":[{"name":"Department of Pharmacology, Welsh School of Pharmacy, Cardiff University , King Edward VII Avenue, Cardiff CF10 3XF,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth J","family":"Broadley","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, Welsh School of Pharmacy, Cardiff University , King Edward VII Avenue, Cardiff CF10 3XF,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2005,11,1]]},"reference":[{"key":"2024103109413795600_cit1","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1136\/adc.86.4.276","article-title":"Short term effects of adrenaline in bronchiolitis: a randomised controlled trial","volume":"86","author":"Abul-ainine","year":"2002","journal-title":"Arch. Dis. Child."},{"key":"2024103109413795600_cit2","first-page":"487","article-title":"\u03b2-agonist aerosol distribution in respiratory syncytial virus bronchiolitis in infants","volume":"43","author":"Amirav","year":"2002","journal-title":"J. Nucl. Med."},{"key":"2024103109413795600_cit3","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1067\/mpd.2000.105358","article-title":"The pharmacologic mechanism by which inhaled adrenaline reduces airway obstruction in respiratory syncytial induced virus-associated bronchiolitis","volume":"136","author":"Barr","year":"2000","journal-title":"J. Pediatr."},{"key":"2024103109413795600_cit4","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1165\/ajrcmb.23.5.3771","article-title":"Surfactant protein-A enhances uptake of respiratory syncytial virus by monocytes and U937 macrophages","volume":"23","author":"Barr","year":"2000","journal-title":"Am. J. Respir. Cell. Mol. Biol."},{"key":"2024103109413795600_cit5","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1136\/adc.61.6.593","article-title":"Ribavirin aerosol for acute bronchiolitis","volume":"61","author":"Barry","year":"1986","journal-title":"Arch. Dis. Child."},{"key":"2024103109413795600_cit6","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.4049\/jimmunol.98.6.1115","article-title":"Repeated infections with respiratory syncytial virus","volume":"98","author":"Beem","year":"1967","journal-title":"J. Immunol."},{"key":"2024103109413795600_cit7","first-page":"1072","article-title":"The interaction of nasopharyngeal (NP) suction and salbutamol in the treatment of bronchiolitis: a two year comparison","volume":"47","author":"Bennion","year":"2001","journal-title":"Respir. Care."},{"key":"2024103109413795600_cit8","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1002\/ppul.1040","article-title":"Efficacy of nebulised adrenaline versus salbutamol in hospitalised infants with bronchiolitis","volume":"31","author":"Bertrand","year":"2001","journal-title":"Pediatr. Pulmonol."},{"key":"2024103109413795600_cit9","first-page":"209","article-title":"Systematic review of the biology and medical management of respiratory syncytial virus infection","volume":"48","author":"Black","year":"2003","journal-title":"Respir. Care."},{"key":"2024103109413795600_cit10","doi-asserted-by":"crossref","first-page":"544","DOI":"10.3181\/00379727-92-22538","article-title":"Recovery of cytopathogenic agent from chimpanzees with coryza","volume":"92","author":"Blount","year":"1956","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"2024103109413795600_cit11","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1517\/14656566.4.10.1801","article-title":"Effectiveness of drug therapies to treat or prevent respiratory syncytial virus infection related morbidity","volume":"4","author":"Broughton","year":"2003","journal-title":"Expert. Opin. Pharmacother."},{"key":"2024103109413795600_cit12","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1086\/340024","article-title":"A randomised, double blind, placebo-controlled trial of dexamethasone in severe respiratory syncytial virus (RSV) infection: effects on RSV quantity and clinical outcome","volume":"185","author":"Buckingham","year":"2002","journal-title":"J. Infect. Dis."},{"key":"2024103109413795600_cit13","doi-asserted-by":"crossref","first-page":"e77","DOI":"10.1542\/peds.104.6.e77","article-title":"Prednisolone treatment of respiratory syncytial virus infection: a randomised controlled trial of 147 infants","volume":"104","author":"Bulow","year":"1999","journal-title":"Pediatrics"},{"key":"2024103109413795600_cit14","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1542\/peds.36.1.21","article-title":"Acute respiratory disease in infancy and childhood: present understanding and prospects for prevention","volume":"36","author":"Channock","year":"1965","journal-title":"Paediatrics"},{"key":"2024103109413795600_cit15","first-page":"281","article-title":"Recovery from infants with respiratory illness of a virus related to chimpanzee coryza agent (CCA)","volume":"66","author":"Channock","year":"1957","journal-title":"Am. J. Hyg."},{"key":"2024103109413795600_cit16","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1136\/adc.83.4.313","article-title":"Respiratory syncytial virus infection in high risk infants and the potential impact of prophylaxis in the United Kingdom cohort","volume":"83","author":"Clark","year":"2000","journal-title":"Arch. Dis. Child."},{"key":"2024103109413795600_cit17","first-page":"1313","article-title":"Respiratory syncytial virus.","volume-title":"Virology.","author":"Collins","year":"2001","edition":"4th"},{"key":"2024103109413795600_cit18","first-page":"137","article-title":"Reassessment of the indications for ribavirin therapy in respiratory syncytial virus infections","volume":"97","author":"Committee on Infectious Disease. American Academy of Paediatrics","year":"1996","journal-title":"Paediatrics"},{"key":"2024103109413795600_cit19","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1542\/peds.112.6.1442","article-title":"Revised indications for the use of palivizumab and respiratory syncytial virus immune globulin intravenous for the prevention of respiratory syncytial infections","volume":"112","author":"Committee on Infectious Diseases and Committee on Foetus and Newborn, American Academy of Paediatrics","year":"2003","journal-title":"Paediatrics"},{"key":"2024103109413795600_cit20","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1097\/00006454-198702000-00003","article-title":"Aerosolised ribavirin treatment of respiratory syncytial virus infection in infants hospitalised during an epidemic","volume":"6","author":"Conrad","year":"1987","journal-title":"Pediatr. Infect. Dis. J."},{"key":"2024103109413795600_cit21","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1136\/adc.75.2.133","article-title":"Surfactant abnormalities in infants with severe viral bronchiolitis","volume":"75","author":"Dargaville","year":"1996","journal-title":"Arch. Dis. Child."},{"key":"2024103109413795600_cit22","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/S0022-3476(97)70044-1","article-title":"Respiratory syncytial virus bronchiolitis; a double-blind dexamethasone efficacy study","volume":"131","author":"De Boeck","year":"1997","journal-title":"J. Pediatr."},{"key":"2024103109413795600_cit23","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1128\/CMR.12.2.298","article-title":"Respiratory syncytial virus infection: immune response, immunopathogenesis, and treatment","volume":"12","author":"Domachowske","year":"1999","journal-title":"Clin. Microbiol. Rev."},{"key":"2024103109413795600_cit24","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1136\/adc.80.4.343","article-title":"Randomised controlled trial of budesonide for the prevention of post-bronchiolitis wheezing","volume":"80","author":"Fox","year":"1999","journal-title":"Arch. Dis. Child."},{"key":"2024103109413795600_cit25","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1136\/adc.59.11.1038","article-title":"Antibiotic treatment of pneumonia and bronchiolitis. A prospective randomised study","volume":"59","author":"Friis","year":"1984","journal-title":"Arch. Dis. Child."},{"key":"2024103109413795600_cit26","first-page":"1","article-title":"Incidence of respiratory syncytial and parainfluenza type 3 viruses in an urban setting","volume":"2","author":"Glezen","year":"1987","journal-title":"Pediatr. Virol."},{"key":"2024103109413795600_cit27","first-page":"239","article-title":"Epidemiology of acute lower respiratory disease in children","volume":"11","author":"Glezen","year":"1973","journal-title":"N. Engl. J. Med."},{"key":"2024103109413795600_cit28","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1186\/cc692","article-title":"Helium-oxygen mixture does not improve gas exchange in mechanically ventilated children with bronchioltis","volume":"4","author":"Gross","year":"2000","journal-title":"Crit Care"},{"key":"2024103109413795600_cit29","first-page":"199","article-title":"Respiratory syncytial virus infection in children with bronchopulmonary dysplasia","volume":"82","author":"Groothuis","year":"1988","journal-title":"Pediatrics"},{"key":"2024103109413795600_cit30","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1086\/517377","article-title":"Safety and immunogenicity of a purified F protein respiratory syncytial virus (PFP-2) vaccine in seropositive children with bronchopulmonary dysplasia","volume":"177","author":"Groothius","year":"1998","journal-title":"J. Infect. Dis."},{"key":"2024103109413795600_cit31","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1086\/313960","article-title":"Nosocomial respiratory syncytial virus infections: the cold war has not ended","volume":"31","author":"Hall","year":"2000","journal-title":"Clin. Infect. Dis."},{"key":"2024103109413795600_cit32","first-page":"2084","article-title":"Respiratory syncytial virus.","volume-title":"Textbook of paediatric infectious diseases","author":"Hall","year":"2003"},{"key":"2024103109413795600_cit33","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/S0022-3476(81)80969-9","article-title":"Modes of transmission of RSV","volume":"99","author":"Hall","year":"1981","journal-title":"J. Pediatr."},{"key":"2024103109413795600_cit34","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0022-3476(76)80918-3","article-title":"Respiratory syncytial virus infections in infants: quantitation and duration of shedding","volume":"89","author":"Hall","year":"1976","journal-title":"J. Pediatr."},{"key":"2024103109413795600_cit35","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1093\/infdis\/141.1.98","article-title":"Possible transmission by fomites of respiratory syncytial virus","volume":"141","author":"Hall","year":"1980","journal-title":"J. Infect. Dis."},{"key":"2024103109413795600_cit36","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1056\/NEJM198306163082403","article-title":"Aerosolised ribavirin treatment of infants with respiratory syncytial virus infection: a randomised double blind study","volume":"308","author":"Hall","year":"1983","journal-title":"N. Engl. J. Med."},{"key":"2024103109413795600_cit37","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1056\/NEJM198607103150201","article-title":"Respiratory syncytial virus in children with compromised immune function","volume":"315","author":"Hall","year":"1986","journal-title":"N. Engl. J. Med."},{"key":"2024103109413795600_cit38","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1093\/infdis\/163.4.693","article-title":"Immunity to and frequency of infection and re-infection with RSV","volume":"163","author":"Hall","year":"1991","journal-title":"J. Infect. Dis."},{"key":"2024103109413795600_cit39","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003123.pub2","article-title":"Epinephrine for bronchiolitis","volume-title":"The Cochrane Database of Systematic Reviews","author":"Hartling","year":"2004"},{"key":"2024103109413795600_cit40","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1056\/NEJM197903083001004","article-title":"Respiratory syncytial virus infections, re-infections and immunity. A prospective longitudinal study in young children","volume":"300","author":"Henderson","year":"1979","journal-title":"N. Engl. J. Med."},{"key":"2024103109413795600_cit41","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/00005792-198909000-00002","article-title":"Respiratory syncytial virus induced acute lung injury in adult patients with bone marrow transplants: a clinical approach and review of the literature","volume":"68","author":"Hertz","year":"1989","journal-title":"Medicine"},{"key":"2024103109413795600_cit42","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1159\/000029317","article-title":"Treatment of respiratory failure with inhaled nitric oxide and high frequency ventilation in an infant with respiratory syncytial virus pneumonia and bronchopulmonary dysplasia","volume":"65","author":"Hoehn","year":"1998","journal-title":"Respiration"},{"key":"2024103109413795600_cit43","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1093\/oxfordjournals.aje.a115826","article-title":"Risk factors for respiratory syncytial virus-associated lower respiratory illnesses in the first year of life","volume":"133","author":"Holberg","year":"1991","journal-title":"Am. J. Epidemiol."},{"key":"2024103109413795600_cit44","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1097\/00003246-199810000-00031","article-title":"Helium-oxygen improves clinical asthma scores in children with acute bronchiolitis","volume":"26","author":"Hollman","year":"1998","journal-title":"Crit. Care Med."},{"key":"2024103109413795600_cit45","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1542\/peds.104.3.419","article-title":"Cost effectiveness of respiratory syncytial virus prophylaxis among preterm infants","volume":"104","author":"Joffe","year":"1999","journal-title":"Paediatrics"},{"key":"2024103109413795600_cit46","doi-asserted-by":"crossref","first-page":"2623","DOI":"10.1099\/0022-1317-69-10-2623","article-title":"The fusion of glycoproteins of human respiratory syncytial virus of subgroup A and B: sequence conservation provides a structural basis for antigenic relatedness","volume":"69","author":"Johnson","year":"1988","journal-title":"J. Gen. Virol."},{"key":"2024103109413795600_cit47","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1086\/514115","article-title":"Development of a humanised monoclonal antibody (MEDI-493) with potent in vitro and in vivo activity against respiratory syncytial virus","volume":"176","author":"Johnson","year":"1997","journal-title":"J. Infect. Dis."},{"key":"2024103109413795600_cit48","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1016\/S0264-410X(98)00381-8","article-title":"The two amino acid substitutions in the L protein of cpts 530\/1009, a live attenuated respiratory syncytial virus candidate vaccine, are independent temperature-sensitive and attenuation mutations","volume":"17","author":"Juhasz","year":"1999","journal-title":"Vaccine"},{"key":"2024103109413795600_cit49","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1001\/archpedi.156.10.1034","article-title":"Economic analysis of respiratory syncytial virus immunoprophylaxis in high-risk infants: a systematic review","volume":"156","author":"Kamal-Bahl","year":"2002","journal-title":"Arch. Pediatr. Adol. Med."},{"key":"2024103109413795600_cit50","article-title":"Bronchodilators for bronchiolitis","volume-title":"The Cochrane Database of Systemic Reviews","author":"Kellner","year":"2000"},{"key":"2024103109413795600_cit51","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1093\/oxfordjournals.aje.a120955","article-title":"Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated virus","volume":"89","author":"Kim","year":"1969","journal-title":"Am. J. Epidemiol."},{"key":"2024103109413795600_cit52","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1001\/archpedi.1996.02170360056009","article-title":"Efficacy of bronchodilator therapy in bronchiolitis: a meta analysis","volume":"150","author":"Klassen","year":"1996","journal-title":"Arch. Pediatr. Adolesc. Med."},{"key":"2024103109413795600_cit53","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1007\/BF01711907","article-title":"Inhaled nitric oxide for a severe respiratory syncytial virus infection in an infant with bronchopulmonary dysplasia","volume":"20","author":"Leclere","year":"1994","journal-title":"Intensive Care Med."},{"key":"2024103109413795600_cit54","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1099\/0022-1317-68-9-2521","article-title":"Demonstration that glycoprotein G is the attachment protein of respiratory syncytial virus","volume":"68","author":"Levine","year":"1987","journal-title":"J. Gen. Virol."},{"key":"2024103109413795600_cit55","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1542\/peds.113.6.1728","article-title":"Risk of serious bacterial infection in young febrile infants with respiratory syncytial virus infections","volume":"113","author":"Levine","year":"2004","journal-title":"Pediatrics"},{"key":"2024103109413795600_cit56","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/S0149-2918(00)83032-5","article-title":"Palivizumab for respiratory syncytial virus prophylaxis in high-risk infants: a cost effective analysis","volume":"22","author":"Lofland","year":"2000","journal-title":"Clin. Ther."},{"key":"2024103109413795600_cit57","first-page":"291","article-title":"Bronchiolitis","volume":"8","author":"Lozano","year":"2002","journal-title":"Clin. Evid."},{"key":"2024103109413795600_cit58","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1056\/NEJM198208123070702","article-title":"Respiratory syncytial viral infection in infants with congenital heart disease","volume":"307","author":"MacDonald","year":"1982","journal-title":"N. Engl. J. Med."},{"key":"2024103109413795600_cit59","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/rmv.423","article-title":"New drugs and treatment for respiratory syncytial virus","volume":"14","author":"Maggon","year":"2004","journal-title":"Rev. Med. Virol."},{"key":"2024103109413795600_cit60","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1378\/chest.123.2.481","article-title":"Nebulised 3% hypertonic saline solution treatment in hospitalised infants with viral bronchiolitis","volume":"123","author":"Mandelberg","year":"2003","journal-title":"Chest"},{"key":"2024103109413795600_cit61","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1542\/peds.109.1.68","article-title":"Heliox therapy in infants with acute bronchiolitis","volume":"109","author":"Martinon-Torres","year":"2002","journal-title":"Paediatrics"},{"key":"2024103109413795600_cit62","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1542\/peds.106.3.520","article-title":"Nosocomial respiratory syncytial virus infections; the cost effectiveness and cost benefit of infection control","volume":"106","author":"McCartney","year":"2000","journal-title":"Paediatrics"},{"key":"2024103109413795600_cit63","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/S0022-3476(05)82443-6","article-title":"Variation in severity of respiratory syncytial virus infections with subtype","volume":"117","author":"McConnochie","year":"1990","journal-title":"J. Paediatr."},{"key":"2024103109413795600_cit64","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1007\/978-1-4899-0036-4_23","article-title":"Respiratory syncytial virus.","volume-title":"Viral infections in humans\u2014epidemiology and control.","author":"McIntosh","year":"1997","edition":"4th"},{"key":"2024103109413795600_cit65","first-page":"1071","article-title":"The effect of NP suctioning on symptom scores in bronchiolitis patients","volume":"47","author":"McKinley","year":"2001","journal-title":"Respir. Care."},{"key":"2024103109413795600_cit66","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S1359-6446(00)01500-2","article-title":"Respiratory syncytial virus: recent progress towards the discovery of effective prophylactic and therapeutic agents","volume":"5","author":"Meanwell","year":"2000","journal-title":"Drug Discov. Today"},{"key":"2024103109413795600_cit67","doi-asserted-by":"crossref","first-page":"S17","DOI":"10.1016\/S0022-3476(94)70186-5","article-title":"Economic impact of viral respiratory disease in children","volume":"124","author":"Meissner","year":"1994","journal-title":"J. Pediatr."},{"key":"2024103109413795600_cit68","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/S0022-3476(95)70234-2","article-title":"A randomised trial comparing the efficacy of adrenaline with salbutamol in the treatment of acute bronchiolitis","volume":"126","author":"Menon","year":"1995","journal-title":"J. Pediatr."},{"key":"2024103109413795600_cit69","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1183\/09031936.01.18040734","article-title":"DNase treatment for atelectasis in infants with severe respiratory syncytial virus bronchiolitis","volume":"18","author":"Merkus","year":"2001","journal-title":"Eur. Respir. J."},{"key":"2024103109413795600_cit70","doi-asserted-by":"crossref","first-page":"3465","DOI":"10.1016\/S0264-410X(03)00352-9","article-title":"Safety and immunogenicity of respiratory syncytial virus purified fusion protein-2 vaccine in pregnant women","volume":"21","author":"Munoz","year":"2003","journal-title":"Vaccine"},{"key":"2024103109413795600_cit71","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1378\/chest.120.1.203","article-title":"Efficacy of recombinant human deoxyribonuclease I in the hospital management of respiratory syncytial virus bronchiolitis","volume":"120","author":"Nasr","year":"2001","journal-title":"Chest"},{"key":"2024103109413795600_cit72","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s001340050791","article-title":"Effect of inhaled nitric oxide on respiratory mechanics in ventilated infants with RSV bronchiolitis","volume":"25","author":"Patel","year":"1999","journal-title":"Intensive Care Med."},{"key":"2024103109413795600_cit73","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1016\/S0264-410X(03)00098-7","article-title":"Immunogenicity of a new purified fusion protein vaccine to respiratory syncytial virus: a multi-centre trial in children with cystic fibrosis","volume":"21","author":"Piedra","year":"2003","journal-title":"Vaccine"},{"key":"2024103109413795600_cit74","first-page":"353","article-title":"Practice variation among paediatric emergency departments in the treatment of bronchiolitis","volume":"11","author":"Plint","year":"2004","journal-title":"Am. Emerg. Med."},{"key":"2024103109413795600_cit75","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1086\/324426","article-title":"Safety and immunogenicity of a novel recombinant subunit respiratory virus vaccine (BBG2Na) in healthy young adults","volume":"184","author":"Power","year":"2001","journal-title":"J. Infect. Dis."},{"key":"2024103109413795600_cit76","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/S0264-410X(03)00570-X","article-title":"The immunogenicity, protective efficacy and safety of BBG2Na, a subunit respiratory syncytial virus (RSV) vaccine candidate, against RSV-B","volume":"22","author":"Power","year":"2003","journal-title":"Vaccine"},{"key":"2024103109413795600_cit77","doi-asserted-by":"crossref","first-page":"10287","DOI":"10.1128\/JVI.74.22.10287-10292.2000","article-title":"Efficacy and safety studies of a recombinant chimeric respiratory syncytial virus FG glycoprotein vaccine in cotton rats","volume":"74","author":"Prince","year":"2000","journal-title":"J. Virol."},{"key":"2024103109413795600_cit78","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1136\/adc.71.5.463","article-title":"Management of acute bronchiolitis","volume":"71","author":"Rakshi","year":"1994","journal-title":"Arch. Dis. Child."},{"key":"2024103109413795600_cit79","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1001\/archpedi.1996.02170300066013","article-title":"Anti-inflammatory therapy reduces wheezing after bronchiolitis","volume":"150","author":"Reijonen","year":"1996","journal-title":"Arch. Pediatr. Adolesc. Med."},{"key":"2024103109413795600_cit80","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0022-3476(98)70316-6","article-title":"Early nebulised budesonide in the treatment of bronchiolitis and the prevention of postbronchiolitic wheezing","volume":"132","author":"Richter","year":"1998","journal-title":"J. Pediatr."},{"key":"2024103109413795600_cit81","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1097\/00006454-198702000-00004","article-title":"Aerosolised ribavirin in the treatment of patients with respiratory syncytial diseases","volume":"6","author":"Rodriguez","year":"1987","journal-title":"Pediatr. Infect. Dis. J."},{"key":"2024103109413795600_cit82","doi-asserted-by":"crossref","first-page":"S46","DOI":"10.1097\/01.inf.0000053885.34703.84","article-title":"Palivizumab prophylaxis of respiratory syncytial virus disease from 1998\u20132002; results from four years of palivizumab usage","volume":"22","author":"Romero","year":"2003","journal-title":"Pediatr. Infect. Dis. J."},{"key":"2024103109413795600_cit83","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/S0140-6736(96)02285-4","article-title":"Dexamethasone in bronchiolitis: a randomised controlled trial","volume":"348","author":"Roosevelt","year":"1996","journal-title":"Lancet"},{"key":"2024103109413795600_cit84","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0022-3476(05)83508-5","article-title":"Effect of racemic adrenaline and salbutamol on clinical score with pulmonary mechanics in infants with bronchiolitis","volume":"122","author":"Sanchez","year":"1993","journal-title":"J. Pediatr."},{"key":"2024103109413795600_cit85","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1067\/mpd.2002.120271","article-title":"Efficacy of oral dexamethasone in outpatients with acute bronchiolitis","volume":"140","author":"Schuh","year":"2002","journal-title":"J. Pediatr."},{"key":"2024103109413795600_cit86","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1001\/jama.282.15.1440","article-title":"Bronchiolitis\u2014associated hospitalisations among US children, 1980\u20131996","volume":"282","author":"Shay","year":"1999","journal-title":"JAMA"},{"key":"2024103109413795600_cit87","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1086\/317655","article-title":"Bronchiolitis-associated mortality and estimates of respiratory syncytial virus-associated deaths among US children, 1979\u20131997","volume":"183","author":"Shay","year":"2001","journal-title":"J. Infect."},{"key":"2024103109413795600_cit88","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1111\/j.1651-2227.1999.tb00186.x","article-title":"Abnormal surfactant composition and activity in severe bronchiolitis","volume":"88","author":"Skeleton","year":"1999","journal-title":"Acta Paediatr. Scand."},{"key":"2024103109413795600_cit89","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1056\/NEJM199107043250105","article-title":"A controlled trial of aerosolised ribavirin in infants receiving mechanical ventilation for severe respiratory syncytial virus infection","volume":"325","author":"Smith","year":"1991","journal-title":"N. Engl. J. Med."},{"key":"2024103109413795600_cit90","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1001\/archpedi.155.1.95","article-title":"The economic burden of respiratory syncytial virus-associated bronchiolitis hospitalisations","volume":"155","author":"Stang","year":"2001","journal-title":"Arch. Pediatr. Adolesc. Med."},{"key":"2024103109413795600_cit91","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1542\/peds.72.5.613","article-title":"Ribavirin aerosol treatment of bronchiolitis associated with respiratory syncytial virus infection in infants","volume":"72","author":"Taber","year":"1983","journal-title":"Paediatrics"},{"key":"2024103109413795600_cit92","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1542\/peds.102.3.531","article-title":"Palivizumab a humanised respiratory syncytial virus monoclonal antibody reduces hospitalisation from RSV infection in high-risk infants","volume":"102","author":"The Impact-RSV Study Group","year":"1998","journal-title":"Paediatrics"},{"key":"2024103109413795600_cit93","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1542\/peds.99.1.93","article-title":"Reduction of respiratory syncytial virus hospitalisation among premature infants and infants with bronchopulmonary dysplasia using respiratory syncytial virus immune globulin prophylaxis","volume":"99","author":"The PREVENT Study Group","year":"1997","journal-title":"Paediatrics"},{"key":"2024103109413795600_cit94","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1164\/ajrccm.162.4.9909004","article-title":"Exogenous surfactant supplementation in infants with respiratory syncytial virus bronchiolitis","volume":"162","author":"Tibby","year":"2000","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"2024103109413795600_cit95","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/1099-0496(200008)30:2<131::AID-PPUL8>3.0.CO;2-S","article-title":"Novel pathways in the pathogenesis of respiratory syncytial virus disease","volume":"30","author":"Van Schaik","year":"2000","journal-title":"Pediatr. Pulmonol."},{"key":"2024103109413795600_cit96","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1136\/thx.52.7.634","article-title":"Randomised double blind placebo controlled trial of prednisolone in children admitted to hospital with respiratory syncytial virus bronchiolitis","volume":"52","author":"Van Woensel","year":"1997","journal-title":"Thorax"},{"key":"2024103109413795600_cit97","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1136\/thorax.58.5.383","article-title":"Dexamethasone for treatment of patients mechanically ventilated for lower respiratory tract infection caused by respiratory syncytial virus","volume":"58","author":"Van Woensel","year":"2003","journal-title":"Thorax"},{"key":"2024103109413795600_cit98","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD000181.pub2","article-title":"Ribavirin for respiratory syncytial virus infection of the lower respiratory tract in infants and young children","volume-title":"The Cochrane Database of Systematic Reviews","author":"Ventre","year":"2004"},{"key":"2024103109413795600_cit99","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1086\/513976","article-title":"Severity of respiratory syncytial virus infection is related to virus strain","volume":"175","author":"Walsh","year":"1997","journal-title":"J. Infect. Dis."},{"key":"2024103109413795600_cit100","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1128\/JVI.73.2.871-877.1999","article-title":"Addition of a mis-sense mutation present in the L gene respiratory syncytial virus (RSV) cpts 530\/1030 to RSV vaccine candidate cpts 248\/404 increases its attenuation and temperature sensitivity","volume":"73","author":"Whitehead","year":"1999","journal-title":"J. Virol."},{"key":"2024103109413795600_cit101","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1086\/315859","article-title":"Evaluation of a live, cold-passaged, temperature-sensitive respiratory syncytial virus vaccine in infancy","volume":"182","author":"Wright","year":"2000","journal-title":"J. Infect. Dis."},{"issue":"Suppl. B","key":"2024103109413795600_cit102","doi-asserted-by":"crossref","first-page":"S31","DOI":"10.1053\/rmed.2002.1298","article-title":"Development of a potent respiratory syncytial virus-specific monoclonal antibody for the prevention of serious lower respiratory tract disease in infants","volume":"96","author":"Young","year":"2002","journal-title":"Respir. Med."},{"key":"2024103109413795600_cit103","first-page":"1071","article-title":"The association between nasopharyngeal suction and oxygen requirements in bronchiolitis patients","volume":"47","author":"Zemlicka-Dunn","year":"2001","journal-title":"Respir. Care."}],"container-title":["Journal of Pharmacy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1211%2Fjpp.57.11.0001","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jpp\/article-pdf\/57\/11\/1371\/60261656\/jpp.57.11.0001.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jpp\/article-pdf\/57\/11\/1371\/60261656\/jpp.57.11.0001.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,31]],"date-time":"2024-10-31T10:25:17Z","timestamp":1730370317000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jpp\/article\/57\/11\/1371\/6147622"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,11,1]]},"references-count":103,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2005,11,1]]},"published-print":{"date-parts":[[2005,11,1]]}},"URL":"https:\/\/doi.org\/10.1211\/jpp.57.11.0001","relation":{},"ISSN":["0022-3573","2042-7158"],"issn-type":[{"value":"0022-3573","type":"print"},{"value":"2042-7158","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2005,11]]},"published":{"date-parts":[[2005,11,1]]}}}